JPRN-jRCT1030200267
Recruiting
未知
A single-center, prospective, observational study investigating the levels of insulin antagonist hormones on diabetic ketosis and hyperglycemic emergencies on admission
Suzuki Agena0 sites30 target enrollmentDecember 24, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- diabetes mellitus
- Sponsor
- Suzuki Agena
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) A person who is 16 years or older at the time of obtaining consent.
- •2\) A person who is diagnosed diabetic ketosis or hyperglycemic emergency (diabetic ketoacidosis or hyperosmolar hyperglycemic state). In addition, each condition is defined as follows.
- •a) Diabetic ketosis : pH \>\= 7\.30, and HCO3\- \>\= 18 mEq/L, and ketone is positive.
- •b) Diabetic ketoacidosis : plasma glucose level \> 250 mg/dL, and pH \< 7\.30, and/or HCO3\- \< 18 mEq/L, and keton is positive.
- •c) Hyperosmolar hyperglycemic state : plasma glucose level \> 600 mg/dL, and pH \>\= 7\.30, and HCO3\- \>\= 18 mEq/L, and ketone is negative, and plasma osmorality \>\= 320 mOsm/kg.
- •3\) When the age of a person is between 16 and 19 years at the time of obtaining consent, the person and his/her substitute understand the content of this study and can obtain written consent to participate in the study on sufficient explanation.
- •4\) When a person's Glasgow coma scale is less than or equal 14 points at the time of obtaining consent, sufficient explanation should be given to his/her substitute for participation in this study. Futhermore, the person with the substitute's written consent will participate in the study. We should give sufficient explanation to the person after improving the consciousness level. The person understands the content of this study and can obtain written consent to participate in the study.
- •5\) A person who understands the content of this study and can obtain written consent to participate in the study.
Exclusion Criteria
- •1\) A woman who is in lactation period or who may be pregnant.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Examination of the level of insulin antagonist hormones in hyperglycemic emergencies on admission.diabetes mellitusJPRN-UMIN000046105Kitasato University, School of Medicine27
Not yet recruiting
Not Applicable
Accuracy of continuous glucose monitoring in cardiac surgeryNot ApplicableKCT0009396The Catholic University of Korea, Seoul St. Mary's Hospital42
Completed
Not Applicable
Efficacy of Double Carbapenem regimen against Carbapenem resistant Enterobacteriaceae infectionsCTRI/2021/01/030762Roopali Somani46
Not yet recruiting
Not Applicable
Estimating the lacrimal punctum size in an adult populatioacrimal Punctum SizeLacrimal Punctum SizeEye - Diseases / disorders of the eyeACTRN12611000273987Royal Adelaide Hospital100
Active, not recruiting
Phase 1
Study to investigate the performance of a newly developed patch insulin pump in patients with type 2 diabetesType 2 diabetes mellitusMedDRA version: 17.1Level: PTClassification code 10053247Term: Insulin-requiring type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2014-004078-40-ATCeQur Corp.